History and Mission
Message From the Chair
Media | Press Releases
Board of Directors
What Is the CFA Charter Program?
The CFA® Program
Exam Details and Registration
CFA Exam Tip Fact Card
Kaplan Schweser Partnership
2019 CFA Charterholders
Programs and Events
Market Dinner 2020
CFA Institute Research Challenge
About the Research Challenge
Industry Related Events and Offers
Programs and Education Advisory Council
CFA Boston Programming Policies
Market Dinner 2020
Financial Literacy Initiative
Financial Literacy Initiative Information
Understanding Personal Finances
Financial Literacy Presentation Options
Women's Internship Information Session
Sustainable Investing Initiative
Sustainable Investing Video Series
CFA Investment Foundations Program
Continuing Education (CE)
New CFA Charterholders 2019
Women In Investment Management Internship Program
State Street Global Advisors
0 item(s) ($0.00)
Your cart is empty.
Become a CFA Boston Member
Programs & Events
Event Registration - Webinar - Genomics and Biotech Innovation in the Battle Against COVID-19
Wednesday, June 03, 2020
12:00 PM - 1:15 PM Eastern Daylight Time
[add to calendar]
Genomics and Biotech Innovation in the Battle Against COVID-19
As the world is gripped by the COVID-19 crisis, innovations in the genomics and biotech space continue to press ahead. In fact, the speed and cost of DNA sequencing has improved in such a way that scientists were able to sequence the virus behind COVID-19 in a matter of days, compared to the months it took to do the same for SARS. Furthermore, various innovative biotech companies are experimenting with unconventional treatments that could offer promise in treating and preventing the spread of this disease.
Join us for a webinar on June 3, 2020 as CFA Society Boston hosts Cathie Wood, CEO, CIO and founder of ARK Invest, along with Simon Barnett and Ali Urman, ARK's Genomic Revolution Analysts. We'll explore the current genomics landscape, the various non-conventional treatment methods that are being developed, and the implications of these innovations beyond the immediate need to defeat COVID-19.
Catherine D. Wood, Founder, CEO, CIO
Cathie registered ARK Investment Management LLC ("ARK") as an investment adviser with the U.S. Securities and Exchange Commission in January 2014. Focused solely on disruptive innovation, ARK aims to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around genome sequencing, robotics, artificial intelligence, energy storage, and blockchain technology.
Prior to ARK, Cathie spent twelve years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies where she managed over $5 billion. Cathie joined Alliance Capital from Tupelo Capital Management, a hedge fund she co-founded which, in 2000, managed $800 million in global thematic strategies. Prior to her tenure at Tupelo Capital, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. She started her career in Los Angeles, California at The Capital Group as an Assistant Economist. Cathie received her Bachelor of Science, summa cum laude, in Finance and Economics from the University of Southern California in 1981.
In 2018, editors at Bloomberg acknowledged Cathie by selecting her to its second annual Bloomberg 50 list of people across business, entertainment, finance, politics, technology, and science who have defined global business. Additionally, Fortune named Cathie to its exclusive roundtable of experts in the annual Fortune Investors Guide: The Best Investing Advice for 2019 From Fortune's Experts. In 2016, Cathie received the "Women in Finance - Outstanding Contribution Award" from Market Media, and she was a featured speaker at the World Economic Forum (China) in 2016 & 2017, and the World Strategic Forum (Miami) in 2017
Simon Barnett, Genomic Revolution Analyst
Simon joined ARK in October 2018. His focus is on molecular diagnostics, next generation DNA sequencing, nano-biotechnology, microfluidics, and tissue constructs. Prior to ARK, Simon was a finance and operations intern at Aditus Holdings, a financial technology company based in Mexico City. Previously, Simon was an engineering intern at Tissue Analytics, a software firm that utilizes computer vision and machine learning to analyze chronic wounds. Simon graduated from the Johns Hopkins University in 2018 with a degree in Chemical and Biomolecular Engineering focused on Molecular and Cellular Bioengineering.
Ali Urman, Genomic Revolution Analyst
Alexandra (Ali) joined ARK as a Genomics analyst in February 2020. Her focus is on gene editing and novel immunotherapy technologies. Prior to ARK, Alexandra conducted clinical cancer research at Memorial Sloan Kettering Cancer Center and Montefiore Medical Center and was a Senior Research Program Manager at IBM Watson Health. She also created her on consulting firm in 2018. Alexandra has a Masters in Epidemiology and Community Health.
This webinar is complimentary is open to members and non-members. Registrants will receive dial-in information one day prior to the event.
Registration through CFA Society Boston is closed.
Tell a friend
Please, make sure that you have entered valid email addresses!
Generate New Image
Get Audio Code
Type the code from the image
Please, reenter the code in the captcha!
The link was successfully Sent!
Ooops!:( An error has occurred!
Item added to cart!
Your cart is empty.